Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.
One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achie...
Main Authors: | Rong Rong, Bing Li, Rebecca M Lynch, Richard E Haaland, Megan K Murphy, Joseph Mulenga, Susan A Allen, Abraham Pinter, George M Shaw, Eric Hunter, James E Robinson, S Gnanakaran, Cynthia A Derdeyn |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-09-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC2741593?pdf=render |
Similar Items
-
P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape
by: Gnanakaran S, et al.
Published: (2009-10-01) -
Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
by: Murphy, M, et al.
Published: (2013) -
Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
by: Megan K Murphy, et al.
Published: (2013-02-01) -
P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of <it>in vitro </it>replication
by: Derdeyn CA, et al.
Published: (2009-10-01) -
HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
by: Basu Debby, et al.
Published: (2012-09-01)